Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q2 2020 Earnings Call

Investor webinar replay

Replay transcript excerpt

and welcome to the Corbis Pharmaceuticals second quarter August 6, 2020 earnings conference call. As a reminder, all participants are in a listen only mode. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Following the formal presentation, there will be a question and answer session. This conference is being recorded at the company's request and will be available on the company's website following the end of the call. I will now turn the conference over to your host, Ted Jenkins, Senior Director, Investor Relations and Corporate Communications. Please go ahead, sir. Thank you, Brock. Good morning, everyone. At this time, I'd like to remind our listeners that remarks made during this call may state management's intentions, hopes, beliefs, expectations, or projections for the future. These are forward-looking statements that involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws. These forward-looking statements are based on Corvus's current expectations and actual results could differ materially. As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results to differ materially from those contemplated by such forward-looking statements are discussed in the periodic reports Corvus files with Securities and Exchange Commission. These documents are available in the Investors section of the company's website and on the Securities and Exchange Commission's website. We encourage you to review these documents carefully. Joining me on the call today are Dr. Yuval Cohen, our Chief Executive Officer, Dr. Barbara White, our Chief Medical Offic...